Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
4
×
glaxosmithkline
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
4
×
novartis
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
akcea therapeutics
clinical trials
gene therapy
medical devices
nonalcoholic steatohepatitis
abbvie
amgen
anemia
avexis
biogen
What
roundup
bio
biotech
cancer
days
news
abbvie’s
according
ahead
akcea
allogene
august
biofourmis
bucks
busy
cases
celebrate
centers
chance
cigarettes
control
corner
crispr
day
deaths
decisions
devices
disease
diversity
drugs
electronic
fda
forward
holiday
hot
immunotherapy
including
injuries
investors
ipo
Language
unset
Current search:
glaxosmithkline
×
fda
×
" new york top stories "
×
novartis
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More